Hypermarcas negotiates sale of diaper business
Hypermarcas negocia venda do negócio de fraldas
Intel ID : 224981
Synopsis |
Hypermarcas (BVMF: HYPE3), a retailer based in São Paulo, is negotiating the sale of its children and geriatric diapers, as published by newspaper Valor Econômico on 7 May 2015. Merrill Lynch Brazil may have been hired as an advisor in this possible sale to six foreign groups, which would have expressed their interest. In addition, Bradesco BBI Bank and Citibank Brasil may also been involved in helping this deal. According to a undisclosed source, this deal value would be USD 2bn, which represents twice the annual net revenue of the business. Hypermarcas has diaper production lines located in Senador Canedo and Aparecida de Goiânia, Goiás state, and in Mogi das Cruzes, in São Paulo state.
(content in portuguese)
A Hypermarcas (BVMF:HYPE3), empresa varejista com sede em São Paulo, estaria negociando a venda de seu negócio de fraldas descartáveis infantis e geriátricas, publicou o Valor Econômico em 7 de maio 2015. O Merrill Lynch Brasil teria sido contrato para assessorar a companhia na possível venda para os seis grupos estrangeiros que já teriam manifestado interesse. E o Banco Bradesco BBI e o Citibank Brasil também estariam auxiliando a operação. De acordo com uma fonte, cujo não foi revelado, o valor da transação seria de BRL 2bi, isto é, duas vezes a receita líquida anual do negócio colocado a venda. A Hypermarcas tem linhas de produção de fraldas nas cidades de Senador Canedo e Aparecida de Goiânia, no estado do Goiás, e na cidade Mogi das Cruzes no estado de São Paulo. |
|
Intel ID | 224981 | |
Value | EUR 584,49m | |
Native Currency |
Brazilian Real (BRL)
Exchange Rate: ![]() |
|
Financial Data - Hypera Pharma
(31 Dec 2024) |
Revenue: EUR 1.161,85m EBITDA: EUR 327,99m Net Debt: EUR 1.192,80m Exchange Rate: ![]() |
|
Date |
![]() |
|
Country | ![]() |
|
Region | ||
Continent | ![]() |
|
Geography | ![]() |
|
Subsector (Old TTR Sectors) |
|
|
Type |
![]() |
|
Intel Grade |
![]() |
|
Source |
![]() |
|
Tags | ![]() |
Seller
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Secondary Sectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Financial Advisory
Parties | Advisor | Notes from Advisors | |||||
---|---|---|---|---|---|---|---|
|
|
- | |||||
|
- | ||||||
|
- |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.